Active Solicitation · DEPT OF DEFENSE
AI Summary
The Department of Defense requires FDA-approved fentanyl/norfentanyl immunoassay reagent kits for use with Beckman Coulter AU5800 systems. The kits must detect fentanyl/norfentanyl in human urine and support up to 500,000 tests monthly over a five-year period. Interested vendors should refer to the attached Statement of Work and Solicitation N0018926RB011 for further details.
The Department of War (DoW) Drug Demand Reduction Program (DDRP) has a requirement for Food & Drug Administration (FDA) and Quality Management Documented Fentanyl/Norfentanyl Immunoassay Reagent Kits for use with the currently installed Beckman Coulter AU5800 series systems. The reagents shall be capable of detecting fentanyl/norfentanyl in human urine samples. The reagent kits are required for an ordering period of five (5) years. The estimated number of tests shall accommodate up to 500,000 tests per month. Please see attached Statement of Work and copy of Solicitation N0018926RB011.
N0018926RB011 - Drug Demand Reduction Program, Fentanyl/Norfentanyl Immunoassay Reagent Kits is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.